Related references
Note: Only part of the references are listed.HIV-GRADE: A Publicly Available, Rules-Based Drug Resistance Interpretation Algorithm Integrating Bioinformatic Knowledge
Martin Obermeier et al.
INTERVIROLOGY (2012)
Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity
Noortje M. van Maarseveen et al.
RETROVIROLOGY (2012)
Transmitted Antiretroviral Drug Resistance in Individuals with Newly Diagnosed HIV Infection: South Carolina 2005-2009
Eren Youmans et al.
SOUTHERN MEDICAL JOURNAL (2011)
HIV-1 Drug Resistance Transmission Networks in Southwest Switzerland
Erika Castro et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
Antiretroviral Treatment of Adult HIV Infection 2010 Recommendations of the International AIDS Society-USA Panel
Melanie A. Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Low Prevalence of Transmitted Drug Resistance Among Newly Diagnosed HIV-1 Patients in Latvia
Dace Balode et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Reduced Fitness in Cell Culture of HIV-1 with Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Mutations Correlates with Relative Levels of Reverse Transcriptase Content and RNase H Activity in Virions
Jiong Wang et al.
JOURNAL OF VIROLOGY (2010)
Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time
Dineke Frentz et al.
PLOS ONE (2010)
Transmitted Drug Resistance in Persons with Acute/Early HIV-1 in San Francisco, 2002-2009
Vivek Jain et al.
PLOS ONE (2010)
Maintaining Reduced Viral Fitness and CD4 Response in HIV-Infected Patients with Viremia Receiving a Boosted Protease Inhibitor
Philip Grant et al.
CLINICAL INFECTIOUS DISEASES (2009)
Molecular Characterization of Clinical Isolates of Human Immunodeficiency Virus Resistant to the Protease Inhibitor Darunavir
Klara Grantz Saskova et al.
JOURNAL OF VIROLOGY (2009)
Inhibition of the HIV-1 and HIV-2 proteases by a monoclonal antibody
Julien Lescar et al.
PROTEIN SCIENCE (2009)
Gag Mutations Strongly Contribute to HIV-1 Resistance to Protease Inhibitors in Highly Drug-Experienced Patients besides Compensating for Fitness Loss
Elisabeth Dam et al.
PLOS PATHOGENS (2009)
Potent inhibition of drug-resistant HIV protease variants by monoclonal antibodies
Vanda Bartonova et al.
ANTIVIRAL RESEARCH (2008)
Ninety-nine is not enough:: Molecular characterization of inhibitor-resistant human immunodeficiency virus type 1 protease mutants with insertions in the flap region
Milan Kozisek et al.
JOURNAL OF VIROLOGY (2008)
Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
Lin Shen et al.
NATURE MEDICINE (2008)
Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir
Klara Grantz Saskova et al.
PROTEIN SCIENCE (2008)
Vertically acquired paediatric HIV infection: the challenges of providing comprehensive packages of care in resource-limited settings
K. E. Little et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2008)
Drug-associated changes in amino acid residues in Gag p2, p7NC, and p6Gag/p6Pol in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response
Sarah K. Ho et al.
VIROLOGY (2008)
Structural characterization of B and non-B subtypes of HIV-protease: Insights into the natural susceptibility to drug resistance development
Mario Sanches et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Persistence of HIV-1 variants with multiple protease inhibitor (PI)-resistance mutations in the absence of PI therapy can be explained by compensatory fixation
Noortje M. van Maarseveen et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism
Monique Nijhuis et al.
PLOS MEDICINE (2007)
HKL-3000:: the integration of data reduction and structure solution -: from diffraction images to an initial model in minutes
Wladek Minor et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
Co-evolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate
M Kolli et al.
VIROLOGY (2006)
From nonpeptide toward noncarbon protease inhibitors:: Metallacarboranes as specific and potent inhibitors of HIV protease
P Cígler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Inhibitor binding at the protein interface in crystals of a HIV-1 protease complex
J Brynda et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor
NM King et al.
JOURNAL OF VIROLOGY (2004)
Construction and characterisation of a full-length infectious molecular clone from a fast replicating, X4-tropic HIV-1CRF02.AG primary isolate
DM Tebit et al.
VIROLOGY (2003)
ClustalW-MPI: ClustalW analysis using distributed and parallel computing
KB Li
BIOINFORMATICS (2003)
A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance
S Muzammil et al.
BIOCHEMISTRY (2003)
Unusual binding mode of an HIV-1 protease inhibitor explains its potency against multi-drug-resistant virus strains
J Weber et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir
HCF Cote et al.
JOURNAL OF VIROLOGY (2001)
An approach to multi-copy search in molecular replacement
A Vagin et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2000)
Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: Virus fitness in the absence and in the presence of drug
F Mammano et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
